文献速递冠心病血脂与心血管预防

负荷心脏磁共振成像对疑似冠心病患者的风险重分类评估

Evaluation of Stress Cardiac Magnetic Resonance Imaging in Risk Reclassification of Patients With Suspected Coronary Artery Disease.
PubMed 文献 · JAMA Cardiol · 2020-01-01

这项多中心回顾性队列研究纳入1698例无冠心病史但疑诊心肌缺血的35-85岁患者,中位随访5.4年。负荷心脏磁共振成像可在指南推荐的风险类别基础上对患者进行风险重分类,尤其对中等风险患者的临床决策具有支持价值。

要点

  • 负荷心脏磁共振成像可在临床风险因素基础上对疑似冠心病患者进行风险重分类。
  • 对心血管死亡/非致死性心肌梗死,加入负荷心脏磁共振指标后净重分类改善为0.266(95%CI 0.091-0.441)。
  • 中等风险患者中约60%被重分类,低风险重分类后年事件率0.6%,高风险为4.9%。

核心结论

  • 在无冠心病史且疑诊心肌缺血的患者中,负荷心脏磁共振成像可在指南推荐的风险类别基础上跨类别重分类患者风险。
  • 研究结果支持负荷心脏磁共振成像用于临床决策,尤其是对心血管死亡和非致死性心肌梗死中等风险的患者。

研究设计与样本

  • 回顾性、多中心队列研究,在11个美国州的13个中心开展。
  • 纳入1698例年龄35至85岁、有2个或以上冠状动脉危险因素但无冠心病史、疑诊心肌缺血并接受负荷心脏磁共振成像的连续患者。
  • 中位随访5.4年(四分位间距4.6-6.9年)。

主要发现

  • 1698例患者中873例为男性(51.4%),平均(标准差)年龄62(11)岁,共发生67例心血管死亡/非致死性心肌梗死和190例主要不良心血管事件。
  • 对心血管死亡/非致死性心肌梗死,在包含验证的CAD Consortium评分、高血压、吸烟和糖尿病的模型中加入负荷心脏磁共振评估的左心室射血分数、缺血存在和晚期钆增强,净重分类改善为0.266(95%CI 0.091-0.441),C统计量改善为0.086(95%CI 0.022-0.149)。
  • 负荷心脏磁共振成像将中等 pretest 风险类别中60.3%的患者重分类(52.4%重分类为低风险,7.9%为高风险),低 posttest 风险年事件率为0.6%,高 posttest 风险年事件率为4.9%。
  • 对主要不良心血管事件,负荷心脏磁共振成像进一步提供显著净重分类改善(0.361;95%CI 0.255-0.468)和C统计量改善(0.092;95%CI 0.054-0.131),并将中等 pretest 风险组中59.9%的患者重分类(48.7%重分类为低风险,11.2%为高风险)。

关键数值与推荐

  • 指南基于的风险类别:低风险(<1%/年)、中等风险(1%-3%/年)、高风险(>3%/年)。
  • 对心血管死亡/非致死性心肌梗死,加入负荷心脏磁共振指标后净重分类改善0.266(95%CI 0.091-0.441),C统计量改善0.086(95%CI 0.022-0.149)。
  • 对主要不良心血管事件,净重分类改善0.361(95%CI 0.255-0.468),C统计量改善0.092(95%CI 0.054-0.131)。

临床怎么用

  • 对无冠心病史但疑诊心肌缺血的患者,可考虑使用负荷心脏磁共振成像评估左心室射血分数、缺血和晚期钆增强,以辅助风险分层。
  • 对心血管死亡和非致死性心肌梗死中等风险的患者,负荷心脏磁共振成像的重分类结果可能有助于临床决策。

局限性

  • 本研究为回顾性队列研究。
  • 研究未涉及其他可能影响风险重分类的因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The role of stress cardiac magnetic resonance (CMR) imaging in clinical decision-making by reclassification of risk across American College of Cardiology/American Heart Association guideline-recommended categories has not been established. OBJECTIVE: To examine the utility of stress CMR imaging for risk reclassification in patients without a history of coronary artery disease (CAD) who presented with suspected myocardial ischemia. DESIGN, SETTING, AND PARTICIPANTS: A retrospective, multicenter cohort study with median follow-up of 5.4 years (interquartile range, 4.6-6.9) was conducted at 13 centers across 11 US states. Participants included 1698 consecutive patients aged 35 to 85 years with 2 or more coronary risk factors but no history of CAD who presented with suspected myocardial ischemia to undergo stress CMR imaging. The study was conducted from February 18, 2019, to March 1, 2020. MAIN OUTCOMES AND MEASURES: Cardiovascular (CV) death and nonfatal myocardial infarction (MI). Major adverse CV events (MACE) including CV death, nonfatal MI, hospitalization for heart failure or unstable angina, and late, unplanned coronary artery bypass graft surgery. RESULTS: Of the 1698 patients, 873 were men (51.4%); mean (SD) age was 62 (11) years, accounting for 67 CV death/nonfatal MIs and 190 MACE. Clinical models of pretest risk were constructed and patients were categorized using guideline-based categories of low (<1% per year), intermediate (1%-3% per year), and high (>3% year) risk. Stress CMR imaging provided risk reclassification across all baseline models. For CV death/nonfatal MI, adding stress CMR-assessed left ventricular ejection fraction, presence of ischemia, and late gadolinium enhancement to a model incorporating the validated CAD Consortium score, hypertension, smoking, and diabetes provided significant net reclassification improvement of 0.266 (95% CI, 0.091-0.441) and C statistic improvement of 0.086 (95% CI, 0.022-0.149). Stress CMR imaging reclassified 60.3% of patients in the intermediate pretest risk category (52.4% reclassified as low risk and 7.9% as high risk) with corresponding changes in the observed event rates of 0.6% per year for low posttest risk and 4.9% per year for high posttest risk. For MACE, stress CMR imaging further provided significant net reclassification improvement (0.361; 95% CI, 0.255-0.468) and C statistic improvement (0.092; 95% CI, 0.054-0.131), and reclassified 59.9% of patients in the intermediate pretest risk group (48.7% reclassified as low risk and 11.2% as high risk). CONCLUSIONS AND RELEVANCE: In this multicenter cohort of patients with no history of CAD presenting with suspected myocardial ischemia, stress CMR imaging reclassified patient risk across guideline-based risk categories, beyond clinical risk factors. The findings of this study support the value of stress CMR imaging for clinical decision-making, especially in patients at intermediate risk for CV death and nonfatal MI.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Antiochos P, Ge Y, Steel K, et al. Evaluation of Stress Cardiac Magnetic Resonance Imaging in Risk Reclassification of Patients With Suspected Coronary Artery Disease. JAMA Cardiol. 2020. PMID: 32745166. doi:10.1001/jamacardio.2020.2834

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。